Mallinckrodt PLC (MNK) Given Consensus Recommendation of “Hold” by Analysts

Mallinckrodt PLC (NYSE:MNK) has been given a consensus rating of “Hold” by the eighteen analysts that are presently covering the company, Marketbeat reports. Four investment analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation, four have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $30.88.

A number of equities analysts have recently commented on MNK shares. Zacks Investment Research raised shares of Mallinckrodt from a “hold” rating to a “strong-buy” rating and set a $21.00 target price on the stock in a research note on Tuesday, January 8th. ValuEngine downgraded shares of Mallinckrodt from a “hold” rating to a “sell” rating in a research note on Tuesday, March 5th. Morgan Stanley set a $32.00 target price on shares of Mallinckrodt and gave the company a “hold” rating in a research note on Thursday, February 28th. Mizuho reissued a “neutral” rating on shares of Mallinckrodt in a research note on Monday, December 17th. Finally, SunTrust Banks started coverage on shares of Mallinckrodt in a research note on Tuesday, March 19th. They issued a “hold” rating and a $23.00 target price on the stock.

Institutional investors have recently added to or reduced their stakes in the stock. Oregon Public Employees Retirement Fund increased its stake in Mallinckrodt by 1,480.0% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 520,326 shares of the company’s stock worth $33,000 after buying an additional 487,394 shares during the period. FNY Investment Advisers LLC increased its stake in Mallinckrodt by 210.4% during the 4th quarter. FNY Investment Advisers LLC now owns 2,288 shares of the company’s stock worth $36,000 after buying an additional 1,551 shares during the period. We Are One Seven LLC purchased a new stake in Mallinckrodt during the 4th quarter worth $38,000. QS Investors LLC increased its stake in Mallinckrodt by 14.3% during the 4th quarter. QS Investors LLC now owns 4,000 shares of the company’s stock worth $64,000 after buying an additional 500 shares during the period. Finally, Quantamental Technologies LLC purchased a new stake in Mallinckrodt during the 4th quarter worth $80,000.

Shares of MNK opened at $21.70 on Tuesday. The firm has a market capitalization of $1.80 billion, a price-to-earnings ratio of 2.71, a P/E/G ratio of 0.23 and a beta of 2.29. Mallinckrodt has a fifty-two week low of $11.65 and a fifty-two week high of $36.65. The company has a current ratio of 1.51, a quick ratio of 1.17 and a debt-to-equity ratio of 2.10.

Mallinckrodt (NYSE:MNK) last announced its quarterly earnings results on Tuesday, February 26th. The company reported $2.18 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.98 by $0.20. Mallinckrodt had a negative net margin of 134.63% and a positive return on equity of 11.14%. The company had revenue of $834.90 million for the quarter, compared to analyst estimates of $681.45 million. During the same quarter last year, the business earned $2.01 EPS. Mallinckrodt’s revenue for the quarter was up 5.4% on a year-over-year basis. Sell-side analysts forecast that Mallinckrodt will post 8.21 earnings per share for the current fiscal year.

About Mallinckrodt

Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza.

Read More: The components of the Stochastic Momentum Index

Analyst Recommendations for Mallinckrodt (NYSE:MNK)

Receive News & Ratings for Mallinckrodt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mallinckrodt and related companies with MarketBeat.com's FREE daily email newsletter.